Folic acid supplements for narrowed aortic heart valve
Treatments studied
Part of Heart & circulation clinical trials.
This trial studies whether daily folic acid can slow or improve calcific aortic valve disease. It is for people with a mildly to moderately narrowed aortic valve plus calcium seen on a heart CT scan.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 35 years or older
- You have calcific aortic valve disease with mild to moderate narrowing (checked by heart ultrasound and measurements)
- Your heart CT shows enough aortic valve calcium (Agatston score of 200 or higher)
- You can get a cardiac CT scan and follow study visits, and you agree to the trial in writing
- You are not pregnant or breastfeeding
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if the drug vericiguat can slow down the buildup of calcium in the aortic valve, which causes it to narrow and stiffen. If you have mild-to-moderate aortic valve stenosis and meet the other criteria, this study may help protect your valve from getting worse.
This trial tests a new heart valve device (Venus-Vitae) for people with severe aortic stenosis, a condition where the heart valve is too tight. It aims to see if the device works well for patients of all surgical risk levels.
This Phase 2 study tests whether pioglitazone can slow or improve calcific aortic valve disease. It looks for people with mild-to-moderate aortic valve narrowing and high calcium on heart imaging.
This trial is for people with aortic valve disease (aortic valve narrowing, leakage, or a worn-out valve). It tests what the doctors learn from following these patients, and it may help improve future care.
This trial studies whether lowering blood pressure affects health outcomes in people who have valve narrowing in the heart but no valve symptoms yet. It may help you understand which blood pressure targets are safest when the aortic valve is not fully opening.
This trial tests whether the blood pressure medication manidipine can slow or reverse calcium buildup in the heart's aortic valve. Researchers are looking for older adults with mild-to-moderate aortic valve narrowing.
Hear when a new Aortic Valve Stenosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.